# Boxlight Corp: financial statements, quarterly

BOXL · Nasdaq · CIK 1624512 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/boxl.md) · [Financials](/companies/boxl/financials.md) · [Filings](/companies/boxl/filings.md) · [Insiders](/companies/boxl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/boxl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [49.7](/filings/0001628280-24-047932.md) | [38.8 d](/filings/0001628280-25-015455.md) | [37.1](/filings/0001628280-24-021699.md) | [38.5](/filings/0001628280-25-040170.md) | [36.3](/filings/0001628280-25-052307.md) | [24.0 d](/filings/0001628280-26-025273.md) | [22.4](/filings/0001628280-26-035695.md) | [30.9](/filings/0001628280-26-057056.md) | [29.3](/filings/0001628280-25-052307.md) | [26.6 d](/filings/0001628280-26-025273.md) | [22.4](/filings/0001628280-26-035695.md) | [25.9](/filings/0001628280-26-057056.md) |
| Cost of revenue | $m | [31.7](/filings/0001628280-24-047932.md) | [26.5 d](/filings/0001628280-25-015455.md) | [24.3](/filings/0001628280-24-021699.md) | [24.0](/filings/0001628280-25-040170.md) | [24.0](/filings/0001628280-25-052307.md) | [16.7 d](/filings/0001628280-26-025273.md) | [14.4](/filings/0001628280-26-035695.md) | [20.1](/filings/0001628280-26-057056.md) | [20.8](/filings/0001628280-25-052307.md) | [20.4 d](/filings/0001628280-26-025273.md) | [15.5](/filings/0001628280-26-035695.md) | [13.0](/filings/0001628280-26-057056.md) |
| Gross profit | $m | [18.0](/filings/0001628280-24-047932.md) | [12.3 d](/filings/0001628280-25-015455.md) | [12.8](/filings/0001628280-24-021699.md) | [14.5](/filings/0001628280-25-040170.md) | [12.3](/filings/0001628280-25-052307.md) | [7.3 d](/filings/0001628280-26-025273.md) | [8.0](/filings/0001628280-26-035695.md) | [10.8](/filings/0001628280-26-057056.md) | [8.5](/filings/0001628280-25-052307.md) | [6.3 d](/filings/0001628280-26-025273.md) | [6.9](/filings/0001628280-26-035695.md) | [12.9](/filings/0001628280-26-057056.md) |
| Research and development | $m | [1.0](/filings/0001628280-24-047932.md) | [1.1 d](/filings/0001628280-25-015455.md) | [1.2](/filings/0001628280-24-021699.md) | [1.0](/filings/0001628280-25-040170.md) | [1.0](/filings/0001628280-25-052307.md) | [0.9 d](/filings/0001628280-26-025273.md) | [0.9](/filings/0001628280-26-035695.md) | [1.1](/filings/0001628280-26-057056.md) | [1.1](/filings/0001628280-25-052307.md) | [1.1 d](/filings/0001628280-26-025273.md) | [0.9](/filings/0001628280-26-035695.md) | [0.9](/filings/0001628280-26-057056.md) |
| Operating income | $m | [(11.6)](/filings/0001628280-24-047932.md) | [(16.6) d](/filings/0001628280-25-015455.md) | [(3.6)](/filings/0001628280-24-021699.md) | [1.2](/filings/0001628280-25-040170.md) | [(0.9)](/filings/0001628280-25-052307.md) | [(16.2) d](/filings/0001628280-26-025273.md) | [(2.9)](/filings/0001628280-26-035695.md) | [(3.9)](/filings/0001628280-26-057056.md) | [(3.9)](/filings/0001628280-25-052307.md) | [(5.6) d](/filings/0001628280-26-025273.md) | [(4.9)](/filings/0001628280-26-035695.md) | [1.0](/filings/0001628280-26-057056.md) |
| Interest expense | $m | [3.0](/filings/0001628280-23-037856.md) | [2.6 d](/filings/0001628280-24-011246.md) | [2.6](/filings/0001628280-24-021699.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.1](/filings/0001628280-24-047932.md) | [(1.5) d](/filings/0001628280-25-015455.md) | [0.9](/filings/0001628280-24-021699.md) | [(0.1)](/filings/0001628280-25-040170.md) | [(0.0)](/filings/0001628280-25-052307.md) | [(2.7) d](/filings/0001628280-26-025273.md) | [(0.2)](/filings/0001628280-26-035695.md) | [0.3](/filings/0001628280-26-057056.md) | [(0.3)](/filings/0001628280-25-052307.md) | [(0.8) d](/filings/0001628280-26-025273.md) | [(0.4)](/filings/0001628280-26-035695.md) | [(0.3)](/filings/0001628280-26-057056.md) |
| Net income | $m | [(17.8)](/filings/0001628280-24-047932.md) | [(17.7) d](/filings/0001628280-25-015455.md) | [(7.1)](/filings/0001628280-24-021699.md) | [(1.5)](/filings/0001628280-25-040170.md) | [(3.1)](/filings/0001628280-25-052307.md) | [(16.7) d](/filings/0001628280-26-025273.md) | [(3.2)](/filings/0001628280-26-035695.md) | [(4.7)](/filings/0001628280-26-057056.md) | [(6.2)](/filings/0001628280-25-052307.md) | [(9.7) d](/filings/0001628280-26-025273.md) | [(6.5)](/filings/0001628280-26-035695.md) | [0.5](/filings/0001628280-26-057056.md) |
| Diluted EPS | $ per share | [(1.90)](/filings/0001628280-24-047932.md) | not reported | [(0.76)](/filings/0001628280-24-021699.md) | [(0.92)](/filings/0001628280-25-040170.md) | [(1.72)](/filings/0001628280-25-052307.md) | not reported | [(8.45)](/filings/0001628280-26-035695.md) | [(55.00)](/filings/0001628280-26-057056.md) | [(1.88)](/filings/0001628280-25-052307.md) | not reported | [(2.25)](/filings/0001628280-26-035695.md) | [0.34](/filings/0001628280-26-057056.md) |
| Basic EPS | $ per share | [(1.90)](/filings/0001628280-24-047932.md) | not reported | [(0.76)](/filings/0001628280-24-021699.md) | [(0.92)](/filings/0001628280-25-040170.md) | [(1.72)](/filings/0001628280-25-052307.md) | not reported | [(8.45)](/filings/0001628280-26-035695.md) | [(55.00)](/filings/0001628280-26-057056.md) | [(1.88)](/filings/0001628280-25-052307.md) | not reported | [(2.25)](/filings/0001628280-26-035695.md) | [0.34](/filings/0001628280-26-057056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.4](/filings/0001628280-23-037856.md) | [17.3](/filings/0001628280-25-015455.md) | [11.8](/filings/0001628280-24-021699.md) | [7.5](/filings/0001628280-24-036937.md) | [10.5](/filings/0001628280-24-047932.md) | [8.0](/filings/0001628280-26-025273.md) | not reported | [7.6](/filings/0001628280-25-040170.md) | [11.8](/filings/0001628280-25-052307.md) | [9.4](/filings/0001628280-26-057056.md) | [6.9](/filings/0001628280-26-035695.md) | [4.3](/filings/0001628280-26-057056.md) |
| Current assets | $m | [111](/filings/0001628280-23-037856.md) | [104](/filings/0001628280-25-015455.md) | [86.5](/filings/0001628280-24-021699.md) | [85.1](/filings/0001628280-24-036937.md) | [87.4](/filings/0001628280-24-047932.md) | [78.4](/filings/0001628280-26-025273.md) | not reported | [66.2](/filings/0001628280-25-040170.md) | [69.9](/filings/0001628280-25-052307.md) | [69.5](/filings/0001628280-26-057056.md) | [65.5](/filings/0001628280-26-035695.md) | [62.7](/filings/0001628280-26-057056.md) |
| Total assets | $m | [180](/filings/0001628280-23-037856.md) | [162](/filings/0001628280-25-015455.md) | [142](/filings/0001628280-24-021699.md) | [141](/filings/0001628280-25-040170.md) | [143](/filings/0001628280-25-052307.md) | [115](/filings/0001628280-26-025273.md) | not reported | [99.2](/filings/0001628280-25-040170.md) | [99.6](/filings/0001628280-25-052307.md) | [97.5](/filings/0001628280-26-057056.md) | [90.7](/filings/0001628280-26-035695.md) | [84.4](/filings/0001628280-26-057056.md) |
| Current liabilities | $m | [49.6](/filings/0001628280-23-037856.md) | [49.4](/filings/0001628280-25-015455.md) | [39.9](/filings/0001628280-24-021699.md) | [40.7](/filings/0001628280-25-040170.md) | [42.8](/filings/0001628280-25-052307.md) | [77.0](/filings/0001628280-26-025273.md) | not reported | [66.7](/filings/0001628280-25-040170.md) | [68.4](/filings/0001628280-25-052307.md) | [42.9](/filings/0001628280-26-057056.md) | [40.2](/filings/0001628280-26-035695.md) | [66.7](/filings/0001628280-26-057056.md) |
| Total liabilities | $m | [121](/filings/0001628280-23-037856.md) | [117](/filings/0001628280-25-015455.md) | [105](/filings/0001628280-24-021699.md) | [105](/filings/0001628280-25-040170.md) | [108](/filings/0001628280-25-052307.md) | [99.7](/filings/0001628280-26-025273.md) | not reported | [91.3](/filings/0001628280-25-040170.md) | [90.5](/filings/0001628280-25-052307.md) | [96.3](/filings/0001628280-26-057056.md) | [92.7](/filings/0001628280-26-035695.md) | [85.8](/filings/0001628280-26-057056.md) |
| Long-term debt | $m | [43.4](/filings/0001628280-23-037856.md) | [39.1](/filings/0001628280-25-015455.md) | [37.4](/filings/0001628280-24-021699.md) | [37.1](/filings/0001628280-24-036937.md) | [37.1](/filings/0001628280-24-047932.md) | [0.0](/filings/0001628280-26-025273.md) | not reported | [39.0](/filings/0001628280-25-040170.md) | [36.7](/filings/0001628280-25-052307.md) | [32.9](/filings/0001628280-26-057056.md) | [32.9](/filings/0001628280-26-035695.md) | [0.0](/filings/0001628280-26-057056.md) |
| Current portion of debt | $m | [1.0](/filings/0001628280-23-037856.md) | [1.0](/filings/0001628280-25-015455.md) | [1.1](/filings/0001628280-24-021699.md) | [3.1](/filings/0001628280-24-036937.md) | [1.7](/filings/0001628280-24-047932.md) | [37.1](/filings/0001628280-26-025273.md) | not reported | [39.0](/filings/0001628280-25-040170.md) | [36.7](/filings/0001628280-25-052307.md) | [1.3](/filings/0001628280-26-057056.md) | [1.3](/filings/0001628280-26-035695.md) | [34.1](/filings/0001628280-26-057056.md) |
| Short-term borrowings | $m | [1.0](/filings/0001628280-23-037856.md) | [1.0](/filings/0001628280-25-015455.md) | [1.1](/filings/0001628280-24-021699.md) | [3.1](/filings/0001628280-24-036937.md) | [1.7](/filings/0001628280-24-047932.md) | [37.1](/filings/0001628280-26-025273.md) | not reported | [39.0](/filings/0001628280-25-040170.md) | [36.7](/filings/0001628280-25-052307.md) | [1.3](/filings/0001628280-26-057056.md) | [1.3](/filings/0001628280-26-035695.md) | [34.1](/filings/0001628280-26-057056.md) |
| Shareholders' equity | $m | [30.6](/filings/0001628280-24-047932.md) | [16.8](/filings/0001628280-26-025273.md) | [9.1](/filings/0001628280-25-040170.md) | [7.5](/filings/0001628280-25-052307.md) | [6.5](/filings/0001628280-25-052307.md) | [(12.9)](/filings/0001628280-26-057056.md) | [(15.8)](/filings/0001628280-26-057056.md) | [(20.6)](/filings/0001628280-26-057056.md) | [(19.5)](/filings/0001628280-25-052307.md) | [1.3](/filings/0001628280-26-057056.md) | [(2.0)](/filings/0001628280-26-057056.md) | [(1.4)](/filings/0001628280-26-057056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [8,232 d](/filings/0001628280-24-047932.md) | [3,339 d](/filings/0001628280-25-015455.md) | [(1,942)](/filings/0001628280-24-021699.md) | [(5,367) d](/filings/0001628280-25-040170.md) | [5,220 d](/filings/0001628280-25-052307.md) | [1,650 d](/filings/0001628280-26-025273.md) | [(4,680)](/filings/0001628280-26-035695.md) | [(1,167) d](/filings/0001628280-26-057056.md) | [4,039 d](/filings/0001628280-25-052307.md) | [(1,527) d](/filings/0001628280-26-025273.md) | [(5,049)](/filings/0001628280-26-035695.md) | [(2,423) d](/filings/0001628280-26-057056.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | [227 d](/filings/0001628280-26-025273.md) | [127](/filings/0001628280-26-035695.md) | [32.0 d](/filings/0001628280-26-057056.md) | [(1.0) d](/filings/0001628280-25-052307.md) | [(56.0) d](/filings/0001628280-26-025273.md) | [42.0](/filings/0001628280-26-035695.md) | [33.0 d](/filings/0001628280-26-057056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.2](/filings/0001628280-23-037856.md) | [9.4](/filings/0001628280-24-021699.md) | [9.4](/filings/0001628280-24-036937.md) | [9.5](/filings/0001628280-24-047932.md) | [9.7](/filings/0001628280-24-021699.md) | [2.0](/filings/0001628280-25-040170.md) | [2.0](/filings/0001628280-25-052307.md) | [0.4](/filings/0001628280-26-035695.md) | [0.1](/filings/0001628280-26-057056.md) | [3.5](/filings/0001628280-25-052307.md) | [3.0](/filings/0001628280-26-035695.md) | [0.6](/filings/0001628280-26-057056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 667,393 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001628280-26-057056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.